MENLO PARK, Calif.–(BUSINESS WIRE)–Sapphiros, a KKR-backed platform building the next generation of diagnostic technologies, today announced the appointment of Mark Gladwell as Chief Operating Officer and Dr. Niall Armes as Chief Technology Officer. Mr. Gladwell and Dr. Armes will work alongside Sapphiros Executive Chairman Namal Nawana to provide strategic and operational support to the platform’s growing portfolio of innovative, high-growth diagnostics capabilities. The appointment of Dr. Armes is effective immediately, and Mr. Gladwell will join the company on August 23rd.
“I plan to bring a rigorous and analytical perspective to identify and support high-potential companies that can expand access to diagnostics and improve patient health.”
“We are thrilled to welcome Mark and Niall to Sapphiros as we advance our mission to support the next generation of diagnostics by focusing on innovative, patient-centric technologies,” said Mr. Nawana. “Mark brings over two decades of experience managing global operations and delivering transformative value at various leading health care organizations, and Niall’s achievements as a scientist and entrepreneur have revolutionized the diagnostics industry. Their unique experiences and perspectives will further enable Sapphiros to identify and add value to the world’s most innovative diagnostic technologies.”